Mayne Pharma Group Limited (ASX:MYX) Approves Acquisition by Cosette Pharmaceuticals
Scheme Approval
Mayne Pharma Group Limited shareholders voted overwhelmingly in favour of the Scheme of Arrangement, allowing Cosette Pharmaceuticals, Inc. to acquire 100% of the company’s shares. A total of 99.06% of votes cast supported the acquisition.
Voting Results
Of the shareholders present and voting at the meeting, 89.64% approved the Scheme Resolution. The resolution met the required majorities under ASX Listing Rule 3.13.2 and the Corporations Act 2001.
Next Steps
Subject to legal proceedings, Mayne Pharma will seek approval from the Supreme Court of New South Wales for the Scheme at the next court hearing scheduled for 18 September 2025.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
